Magnesium aspartate

Magnesium aspartate
Clinical data
AHFS/Drugs.com	Consumer Drug Information
ATC code	A12CC05 (WHO) ;
Identifiers
	IUPAC name magnesium (2S)-2-amino-4-hydroxy-4-oxobutanoate;
CAS Number	2068-80-6 ;
PubChem CID	16211203;
DrugBank	DB13359 ;
UNII	082H981FMA;
CompTox Dashboard (EPA)	DTXSID40889452 DTXSID10273965, DTXSID40889452 ;
ECHA InfoCard	100.038.806
Chemical and physical data
Formula	C8H12MgN2O8
Molar mass	288.495 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C([C@@H](C(=O)[O-])N)C(=O)O.C([C@@H](C(=O)[O-])N)C(=O)O.[Mg+2];
	InChI InChI=InChI=1S/2C4H7NO4.Mg/c25-2(4(8)9)1-3(6)7;/h22H,1,5H2,(H,6,7)(H,8,9);/q;;+2/p-2/t2*2-;/m00./s1; Key:RXMQCXCANMAVIO-CEOVSRFSSA-L;
	(what is this?) (verify)

Magnesium aspartate is a magnesium salt of L-aspartic acid, an amino acid, with the chemical formula Mg(C₄H₆NO₄)₂(H₂O)₂. It is used as a mineral supplement, and as an ingredient in manufacturing of cosmetics and household products.

As magnesium is an essential micronutrient, the use of magnesium aspartate as a supplement is intended to increase magnesium levels in the body. It is primarily used as a dietary supplement to address magnesium deficiency and is an ingredient in cosmetics and personal care products as a buffering agent. Magnesium aspartate is investigated for its potential in managing conditions such as chronic fatigue, cardiac surgery electrolyte balance, and other magnesium deficiency-related disorders, though it is not approved as a standalone medical treatment in major jurisdictions like the United States or European Union.